A61K 31/427
Not condensed and containing further heterocyclic rings
Official title: not condensed and containing further heterocyclic rings
A61K31/427 (Not condensed and containing further heterocyclic rings) appears on 1,881 US grants and 3,350 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,881
- Published applications
- 3,350
- Assignees
- 1,370
- Inventors
- 7,925
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 9 | 0 |
| 1997 | 26 | 0 |
| 1998 | 19 | 0 |
| 1999 | 22 | 0 |
| 2000 | 24 | 0 |
| 2001 | 26 | 10 |
| 2002 | 27 | 52 |
| 2003 | 41 | 77 |
| 2004 | 26 | 90 |
| 2005 | 25 | 79 |
| 2006 | 41 | 66 |
| 2007 | 22 | 76 |
| 2008 | 32 | 85 |
| 2009 | 23 | 78 |
| 2010 | 28 | 103 |
| 2011 | 46 | 115 |
| 2012 | 54 | 101 |
| 2013 | 83 | 169 |
| 2014 | 119 | 179 |
| 2015 | 107 | 209 |
| 2016 | 130 | 186 |
| 2017 | 131 | 165 |
| 2018 | 99 | 162 |
| 2019 | 134 | 185 |
| 2020 | 108 | 146 |
| 2021 | 85 | 175 |
| 2022 | 94 | 169 |
| 2023 | 73 | 180 |
| 2024 | 77 | 155 |
| 2025 | 89 | 181 |
| 2026 | 56 | 157 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combinatory treatment29 Sep 2026US 12,746,216 B2Arivin Therapeutics Oy
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Pyrazolyl compounds as KV7 channel activators29 Sep 2026US 12,747,237 B2
- Compounds for treatment of excitotoxicity29 Sep 2026US 12,747,238 B2Nyrada Pty Ltd
- Non-hormonal treatment of hot flashes15 Sep 2026US 12,734,151 B1
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Guanidinylated Amphiphilic Tobramycin Derivates and B-Lactam/B-Lactamase Inhibitor Combinations for Treatment of Pseudomonas Aeruginosa Infections8 Oct 2026US 2026/0306524 A1
- Combination therapy for bacterial infections comprising zinc-chelator, beta-lactam antibiotic and serine beta-lactamase inhibitor8 Oct 2026US 2026/0306526 A1Adjutec Pharma AS
- Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof1 Oct 2026US 2026/0294884 A1Insilico Medicine IP Limited
- Humoral modulation in vaccinated and virally infected subjects with granulocyte-macrophage colony-stimulating factor (gm-csf)1 Oct 2026US 2026/0295009 A1Partner Therapeutics, Inc.
Most cited
By later US patents
- Anti-angiogenic compositions and methods of use242US 6,544,544 B2Angiotech Pharmaceuticals, Inc. · 2003
- Method for treatment of idiopathic inflammatory bowel disease (IIBD)229US 5,599,795 A1997
- Compositions and methods of delivery of pharmacological agents161US 7,820,788 B2Abraxis BioScience, LLC · 2010
- Compositions and methods for treating surgical adhesions160US 6,689,803 B2Angiotech Pharmaceuticals, Inc. · 2004
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008